Breaking a three-year silence by the medical and human rights community, a panel of doctors, attorneys, human rights professionals, university professors and ethics experts have called for an investigation into the use of mefloquine on detainees at Guantanamo Naval Prison. The prison camp had instituted in very early 2002 an unprecedented policy of administering full-treatment doses of mefloquine to all incoming detainees at Guantanamo.
|By: Jeff Kaye Friday November 15, 2013 8:30 am|
|By: Jeff Kaye Sunday August 21, 2011 6:45 am|
Senator Dianne Feinstein put out a press release indicating that the Department of Defense should consider taking the anti-malarial drug mefloquine, also known as Lariam, out of the DoD drug formulary as it is too dangerous.
Feinstein also indicated the drug has been administered to military personnel without the safeguards put in place by a 2009 Department of Defense protocol. Moreover, according to the press release, “These service members are now suffering from… preventable neurological side effects….”
And what “preventable neurological side effects” were these?
|By: Jeff Kaye Tuesday August 2, 2011 5:30 am|
Last March, Kurnaz told the German press about the forcible use of drugs on detainees at Guantanamo, including the administration of anti-malarial medications. One article at DW World cited investigatory stories by Jason Leopold and myself on the use of the controversial drug mefloquine on all the Guantanamo detainees.
In the RT video, Kurnaz talks about his stay in Kandahar, imprisoned by the U.S. military before he was shipped to Guantanamo. He was age 19.
|By: Jeff Kaye Thursday July 21, 2011 5:45 pm|
It is difficult to know why the CDPP has decided now to officially go after David Hicks’ royalties. One wonders if it had anything to do with the warm reception and ovation he received when he spoke to “a packed audience of 1000 people at the Sydney Writers’ Festival” last May. At the same event, Hicks “also warned that Julian Assange could face a similar abandonment by the Australian government, if the US government get their hands on him.”
|By: Jeff Kaye Sunday February 13, 2011 7:40 am|
A National Research Council (NRC) 2008 report on a conference on Emerging Cognitive Neuroscience and Related Technologies examined briefly what it characterized as a “contemporary problem,” the possibility of doing research on “war on terror” detainees, removed by the U.S. government from Geneva protections against experiments done on prisoners of war.
|By: Jeff Kaye Tuesday December 21, 2010 6:00 am|
A new story at Truthout, which I co-authored with Jason Leopold, takes up the investigation of the story into the mass drugging of Guantanamo detainees with the controversial drug mefloquine, aka Lariam, which we originally reported earlier this month. In an interview with the former commander of the Guantanamo Naval Hospital, who signed off on the mefloquine use, Captain Albert Shimkus said “There were certain issues we were advised not to talk about.”
|By: Jeff Kaye Sunday December 19, 2010 7:30 am|
According to the transcript of a February 19, 2002 meeting of the Armed Forces Epidemiological Board (AFEB), “[a] number of the detainees have died of the wounds that they arrived with” at Guantanamo. The statement was made by Captain Alan “Jeff” Yund as he discussed “mortuary affairs” at Guantanamo, part of a larger discussion on health issues at the new prison facility. The big question is: why have we never heard of this before? Meanwhile, DoD has issued denials of any deaths at Guantanamo prior to June 2006.
|By: Jeff Kaye Wednesday December 1, 2010 6:40 pm|
Jason Leopold and I have written an investigatory report for Truthout on the mass administration of the controversial antimalarial drug mefloquine (brand name Lariam) to all Guantanamo detainees through 2005. The drug was applied without regard to whether or not a detainee had malaria, and despite the fact there was no malaria in Guantanamo.
Mefloquine has been a controversial drug since it received FDA approval in 1989, as evidence grows regarding its neurotoxicity and propensity to cause very serious neuropsychiatric side effects. “Adverse events” associated with mefloquine include depression, suicidal thoughts and behaviors, intense rage, hallucinations and anxiety. An Army public health physician told us that use of the drug was akin to “pharmacologic waterboarding.”